chronic treatment of parkinsonism with levodopa or levodopa/carbidopa is associated with problems that include dyskinesia , on-off phenomena , hallucinosis , and possible loss of therapeutic efficacy .
C0023570
levodopa
C0353697
levodopa/carbidopa